Estimating the burden of healthcare-associated infections caused by selected multidrug-resistant bacteria Finland, 2010

被引:11
|
作者
Kanerva, Mari [1 ,2 ]
Ollgren, Jukka [1 ]
Hakanen, Antti J. [3 ]
Lyytikainen, Outi [1 ]
机构
[1] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Epidemiol Surveillance & Control Unit, FI-00271 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, FIN-00029 Helsinki, Finland
[3] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Contro, Unit Antimicrobial Resistance, FI-20521 Turku, Finland
关键词
Multidrug-resistant microbes; Healthcare-associated infections; Burden of HAI; Infection control; Resource allocation; ESCHERICHIA-COLI;
D O I
10.1186/2047-2994-1-33
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Knowledge of the burden of healthcare-associated infections (HAI) and antibiotic resistance is important for resource allocation in infection control. Although national surveillance networks do not routinely cover all HAIs due to multidrug-resistant bacteria, estimates are nevertheless possible: in the EU, 25,000 patients die from such infections annually. We assessed the burden of HAIs due to multidrug-resistant bacteria in Finland in 2010. Methods: By combining data from the National Infectious Disease Registry on the numbers of bacteremias caused by Staphylococcus aureus, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Pseudomonas aeruginosa and Acinetobacter spp., and susceptibility data from the National Antimicrobial Resistance Network and the Finnish Hospital Infection Program, we assessed the numbers of healthcare-associated bacteremias due to selected multidrug-resistant bacteria. We estimated the number of pneumonias, surgical site and urinary tract infections by applying the ratio of these infections in the first national prevalence survey for HAI in 2005. Attributable HAI mortality (3.2%) was also derived from the prevalence survey. Results: The estimated annual number of the most common HAIs due to the selected multidrug-resistant bacteria was 2804 (530 HAIs per million), 6% of all HAIs in Finnish acute care hospitals. The number of attributable deaths was 89 (18 per million). Conclusions: Resources for infection control should be allocated not only in screening and isolation of carriers of multidrug-resistant bacteria, even when they are causing a small proportion of all HAIs, but also in preventing all clinical infections.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Estimating the burden of healthcare-associated infections caused by selected multidrug-resistant bacteria Finland, 2010
    Mari Kanerva
    Jukka Ollgren
    Antti J Hakanen
    Outi Lyytikäinen
    [J]. Antimicrobial Resistance and Infection Control, 1
  • [2] HEALTHCARE-ASSOCIATED INFECTIONS BY MULTIDRUG-RESISTANT BACTERIA IN A TERTIARY UROLOGY DEPARTMENT
    Marques, Vera
    Rolo, Francisco
    Silva, Edgar Tavares
    Torres, Alexandra
    Figueiredo, Arnaldo
    Mota, Alfredo
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E52 - E53
  • [3] Healthcare-associated infections by multidrug-resistant bacteria in Andalusia, Spain, 2014 to 2021
    Fernandez-Martinez, Nicolas Francisco
    Rivera-Izquierdo, Mario
    Ortiz-Gonzalez-Serna, Rocio
    Martinez-Ruiz, Virginia
    Lardelli-Claret, Pablo
    Aginagalde-Llorente, Adrian Hugo
    Valero-Ubierna, Maria del Carmen
    Vergara-Diaz, Maria Auxiliadora
    Lorusso, Nicola
    [J]. EUROSURVEILLANCE, 2023, 28 (39)
  • [4] Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections
    Nelson, Richard E.
    Schweizer, Marin L.
    Perencevich, Eli N.
    Nelson, Scott D.
    Khader, Karim
    Chiang, Hsiu-Yin
    Chorazy, Margaret L.
    Blevins, Amy
    Ward, Melissa A.
    Samore, Matthew H.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (10): : 1212 - 1218
  • [5] Prevalence of Multidrug-Resistant Bacteria in Healthcare-Associated Bloodstream Infections at Hospitals in Riyadh, Saudi Arabia
    Banawas, Saeed S.
    Alobaidi, Ahmed S.
    Dawoud, Turki M.
    AlDehaimi, Abdullah
    Alsubaie, Faisal M.
    Abdel-Hadi, Ahmed
    Manikandan, Palanisamy
    [J]. PATHOGENS, 2023, 12 (09):
  • [6] Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil
    Toledo, P. V. M.
    Arend, L. N.
    Pilonetto, M.
    Costa Oliveira, J. C.
    Luhm, K. R.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2012, 80 (04) : 351 - 353
  • [7] The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
    Molton, James S.
    Tambyah, Paul A.
    Ang, Brenda S. P.
    Ling, Moi Lin
    Fisher, Dale A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1310 - 1318
  • [8] Survival capability of healthcare-associated, multidrug-resistant bacteria on untreated and on antimicrobial textiles
    Hanczvikkel, Adrienn
    Vig, Andras
    Toth, Akos
    [J]. JOURNAL OF INDUSTRIAL TEXTILES, 2019, 48 (07) : 1113 - 1135
  • [9] Drivers of press media response to healthcare-associated infections caused by multidrug-resistant organisms: A report from Brazil
    de Azevedo Carazatto, Priscila Zacarias
    Calil, Felipe Francischeti
    Fortaleza, Carlos Magno Castelo Branco
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (03): : 372 - 373
  • [10] A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii
    Teerawattanapong, Nattawat
    Panich, Pornpansa
    Kulpokin, Disorn
    Ranong, Siriwat Na
    Kongpakwattana, Khachen
    Saksinanon, Atibodi
    Goh, Bey-Hing
    Lee, Learn-Han
    Apisarnthanarak, Anucha
    Chaiyakunapruk, Nathorn
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (05): : 525 - 533